• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼部建模与模拟的进展:关键考量因素及案例研究

Advancements in Ocular Modelling and Simulations: Key Considerations and Case Studies.

作者信息

Khan Mohammed Shareef, Murthy Aditya, Ahmed Tausif

机构信息

Biopharmaceutics - Biopharmaceutics and Bioequivalence, Global Clinical Management, Dr. Reddy's Laboratories Ltd, Hyderabad, India.

Biopharmaceutics and Bioanalytical - Global Clinical Management, Dr. Reddy's Laboratories Ltd, Hyderabad, India.

出版信息

AAPS PharmSciTech. 2024 Dec 17;26(1):14. doi: 10.1208/s12249-024-03001-7.

DOI:10.1208/s12249-024-03001-7
PMID:39690355
Abstract

This review paper discusses the key aspects of ocular biopharmaceutics, with emphasis on the crucial role played by ocular compartmental modelling and simulation in deciphering physiological conditions related to various eye diseases. It describes eye's intricate structure and function and the need for precise and targeted drug delivery systems to address prevalent eye conditions. The review categorizes and discusses various formulations employed in ocular drug delivery, delineating their respective advantages and limitations. Additionally, it probes the challenges inherent in diverse routes of drug administration for ocular therapies and provides insights into the complexities of achieving optimal drug concentrations at the target site within the eye. The central theme of this work is the ocular compartmental modelling and simulations. Hence, this works discusses on the nuanced understanding of physiological conditions within the eye, drug distribution, drug release kinetics, and key considerations for ocular compartmental modelling and simulations. By combining information from various sources, this review aims to serve as a comprehensive reference for researchers, clinicians, and pharmaceutical developers. It covers the multifaceted landscape of ocular biopharmaceutics and the transformative impact of modelling and simulation in optimizing ocular drug delivery strategies.

摘要

这篇综述论文讨论了眼部生物药剂学的关键方面,重点强调了眼部房室建模与模拟在解读与各种眼部疾病相关的生理状况中所起的关键作用。它描述了眼睛复杂的结构和功能,以及为应对常见眼部疾病而开发精确且靶向给药系统的必要性。该综述对眼部给药中使用的各种制剂进行了分类和讨论,阐述了它们各自的优缺点。此外,它探讨了眼部治疗中不同给药途径所固有的挑战,并深入分析了在眼内靶部位实现最佳药物浓度的复杂性。这项工作的核心主题是眼部房室建模与模拟。因此,本文讨论了对眼内生理状况、药物分布、药物释放动力学以及眼部房室建模与模拟的关键考虑因素的细微理解。通过整合来自各种来源的信息,本综述旨在为研究人员、临床医生和制药开发者提供全面的参考。它涵盖了眼部生物药剂学的多方面领域,以及建模与模拟在优化眼部给药策略方面的变革性影响。

相似文献

1
Advancements in Ocular Modelling and Simulations: Key Considerations and Case Studies.眼部建模与模拟的进展:关键考量因素及案例研究
AAPS PharmSciTech. 2024 Dec 17;26(1):14. doi: 10.1208/s12249-024-03001-7.
2
Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations.靶向眼部药物递送:药代动力学/药效学考虑因素。
Pharm Res. 2018 Sep 25;35(11):217. doi: 10.1007/s11095-018-2498-y.
3
Ocular biopharmaceutics: impact of modeling and simulation on topical ophthalmic formulation development.眼生物药剂学:建模与模拟对局部眼科制剂开发的影响。
Drug Discov Today. 2019 Aug;24(8):1587-1597. doi: 10.1016/j.drudis.2019.04.002. Epub 2019 Apr 5.
4
Recent updates on ocular disease management with ophthalmic ointments.眼部软膏在眼病治疗管理方面的最新进展。
Ther Deliv. 2024;15(6):463-480. doi: 10.1080/20415990.2024.2346047. Epub 2024 Jun 11.
5
Recent updates on drug delivery approaches for improved ocular delivery with an insight into nanostructured drug delivery carriers for anterior and posterior segment disorders.药物递送方法的最新进展,以改善眼部递送,并深入了解用于眼前节和眼后节疾病的纳米结构药物递送载体。
Drug Deliv Transl Res. 2025 Jun;15(6):1828-1876. doi: 10.1007/s13346-024-01756-x. Epub 2024 Dec 14.
6
Clinical Ocular Exposure Extrapolation for Ophthalmic Solutions Using PBPK Modeling and Simulation.临床眼部暴露外推法在眼科溶液中的应用:基于 PBPK 建模与模拟。
Pharm Res. 2023 Feb;40(2):431-447. doi: 10.1007/s11095-022-03390-z. Epub 2022 Sep 23.
7
Nanocarrier-Based, ocular drug delivery: Challenges, prospects, and the therapeutic landscape in the United Arab Emirates.基于纳米载体的眼部药物递送:挑战、前景及阿联酋的治疗现状
Int J Pharm. 2024 Dec 25;667(Pt B):124899. doi: 10.1016/j.ijpharm.2024.124899. Epub 2024 Nov 7.
8
Ocular drug delivery-eye on innovation.眼部药物递送——聚焦创新
Drug Deliv Transl Res. 2016 Dec;6(6):631-633. doi: 10.1007/s13346-016-0335-6.
9
Revolutionizing Ophthalmic Care: A Review of Ocular Hydrogels from Pathologies to Therapeutic Applications.革新眼科护理:从病理学至治疗应用的眼用水凝胶综述
Curr Eye Res. 2025 Jan;50(1):1-17. doi: 10.1080/02713683.2024.2396385. Epub 2024 Sep 11.
10
Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases.眼部疾病的基础、挑战和基于纳米医学的解决方案。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019 Jul;11(4):e1548. doi: 10.1002/wnan.1548. Epub 2018 Dec 3.

引用本文的文献

1
A quantum-inspired neural fuzzy sliding mode control framework for fractional-order modeling of intraocular pressure regulation and optic nerve damage in glaucoma.一种用于青光眼眼压调节和视神经损伤分数阶建模的量子启发式神经模糊滑模控制框架。
Sci Rep. 2025 Jul 2;15(1):23438. doi: 10.1038/s41598-025-99501-y.

本文引用的文献

1
Experimental and mathematical approaches for drug delivery for the treatment of wet age-related macular degeneration.用于治疗湿性年龄相关性黄斑变性的药物输送的实验和数学方法。
J Control Release. 2023 Nov;363:464-483. doi: 10.1016/j.jconrel.2023.09.021. Epub 2023 Oct 4.
2
Application of Mechanistic Ocular Absorption Modeling and Simulation to Understand the Impact of Formulation Properties on Ophthalmic Bioavailability in Rabbits: a Case Study Using Dexamethasone Suspension.机制性眼部吸收建模和模拟在理解制剂特性对兔眼部生物利用度影响中的应用:以地塞米松混悬剂为例的研究
AAPS J. 2019 May 20;21(4):65. doi: 10.1208/s12248-019-0334-x.
3
Higuchi equation: derivation, applications, use and misuse.
Higuchi 方程:推导、应用、使用及误用。
Int J Pharm. 2011 Oct 10;418(1):6-12. doi: 10.1016/j.ijpharm.2011.03.051. Epub 2011 Mar 31.
4
Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications.用于治疗视网膜疾病的眼科药物递送系统:从基础研究到临床应用
Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5403-20. doi: 10.1167/iovs.10-5392.
5
Human scleral hydraulic conductivity: age-related changes, topographical variation, and potential scleral outflow facility.人巩膜水导率:与年龄相关的变化、地形变化及潜在的巩膜流出率
Invest Ophthalmol Vis Sci. 2006 Nov;47(11):4942-6. doi: 10.1167/iovs.06-0362.
6
Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging.眼部植入物的药物控释:使用动态三维磁共振成像的评估
Invest Ophthalmol Vis Sci. 2004 Aug;45(8):2722-31. doi: 10.1167/iovs.04-0091.
7
Importance of the noncorneal absorption route in topical ophthalmic drug delivery.非角膜吸收途径在局部眼科药物递送中的重要性。
Invest Ophthalmol Vis Sci. 1985 Apr;26(4):584-7.